Truist cuts Teleflex target to USD 142 from USD 150 for Teleflex stock
Published on 10/18/2026 at 13:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSGuidance and reporting dates
- Truist lowered its Teleflex target to USD 142 on October 14, 2026.
- Teleflex reported USD 570.33 million in second-quarter 2026 revenue.
- Teleflex is scheduled to report third-quarter 2026 results on October 29, 2026.
Teleflex Inc. (ISIN US8793691069) became the subject of a lower Truist price target on October 14, 2026, with the firm cutting its view to USD 142 from USD 150 while retaining a Hold rating, according to Markets Insider. The decision puts the analyst debate ahead of Teleflex's next quarterly report.
Target cut highlights caution
Truist analyst Richard Newitter cited a broader medical-device research note covering third-quarter expectations. The note kept the Hold rating and pointed to investor concern about procedure volumes and capital spending, while also describing US end markets as relatively stable.
Mizuho took a similar position on October 13, 2026, lowering its Teleflex target to USD 140 from USD 145 and maintaining a Neutral rating, as Markets Insider reported.
What does the guidance reset mean?
Teleflex's second-quarter 2026 revenue reached USD 570.33 million, up 28.9 percent from the comparable period on a GAAP basis, while adjusted earnings per share came to USD 1.76. The figures and management's updated outlook were reported by Benzinga.
Management reduced its 2026 pro forma adjusted constant-currency revenue-growth guidance to 3.5 percent to 4.5 percent from 4.5 percent to 5.5 percent. At the same time, adjusted earnings-per-share guidance increased to USD 6.90 to USD 7.20 from USD 6.25 to USD 6.55. The contrast reflects slower interventional integration alongside stronger capital-allocation expectations.
Three milestones frame the update
On August 6, 2026, Teleflex reported second-quarter adjusted earnings per share of USD 1.76 against a USD 1.28 consensus estimate, according to MarketBeat. On October 13, 2026, Mizuho lowered its target to USD 140 from USD 145. On October 14, 2026, Truist followed with a cut to USD 142 from USD 150.
Reporting dates ahead
MarketBeat lists October 29, 2026, before the market opens, as the expected date for Teleflex's third-quarter 2026 results. The same source lists November 5, 2026, at 8:00 a.m. ET for the earnings call.
Stock context for investors
The next report will test whether the integration delays that reduced the revenue outlook are easing while the higher earnings guidance remains intact. Teleflex's medical-device portfolio and planned capital deployment leave execution as the central issue for the next update.
The further course of trading is shown by the continuously updated real-time quote of Teleflex stock.
Teleflex stock facts
- Company: Teleflex Incorporated
- ISIN: US8793691069
- Ticker: TFX
- Primary exchange: NYSE
- Sector / Industry: Healthcare / Medical instruments and supplies
Market context: Market report S&P 500.
